Acquisition

Sam Lyman, a former top Treasury advisor, is now BPI's Head of Research, a move that cements Bitcoin's role in D.C.'s strategic and economic future.

As quantum threats and automation demands reshape cybersecurity, Sectigo appoints a new leader to capitalize on record growth and guide its global expansion.

In a strategic move to fortify national security, X-Bow is acquiring Evolution Space, boosting US rocket motor production and hypersonic capabilities.

Praesidian Capital unites iconic model train maker Lionel with hobby giant Round 2, creating a new collectibles empire focused on innovation and growth.

Agenus activates a key manufacturing pact with Zydus, scaling production for its promising BOT+BAL cancer therapy ahead of regulatory filings and market launch.

Telesat advances its Lightspeed network with new landing stations in Quebec and Saskatchewan, a key step in bridging the digital divide and competing in the LEO race.

Extreme Connect 2026 showcases an AI-first strategy to challenge industry giants, promising a new era of automated, intelligent enterprise networks.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.

Censys launches ARC, a research collective formalizing its mission to protect critical infrastructure by mapping the web's most dangerous exposures.

Industrial AI firm IFS launches a new platform to transform enterprise transport, turning a massive cost center into a strategic, data-driven advantage.

Stonegate Investment Group's $6 billion move to NewEdge's 'Pillar Channel' highlights a new model for advisor monetization and client-centric growth.

A new report shows a 43% surge in AI agent deployment as budgets cease to be a barrier. But with this growth comes a new top priority: accountability.

AI sales platform Structurely appoints mortgage industry veteran Max Wegner as CRO, signaling an aggressive push to solve sales follow-up challenges.

After selling assets and raising cash, Q32 Bio focuses all its resources on bempikibart, a novel drug for hair loss, with pivotal data due in 2026.

iRobot launches its smallest robot yet in Europe, but the Roomba Mini faces giant challenges in a competitive market. Can this tiny cleaner make a big impact?

The marketing tech firm divests a profitable asset to pay down its credit facility and double down on its core AI-driven platform for long-term growth.

ViruSure's new GMP-validated test using Oxford Nanopore sequencing promises to slash drug safety testing times, boosting supply chain resilience.

As California's commercial property market falters, investment firm Azzet plans a major buying spree, leveraging its digital platform to acquire distressed assets.

A new report projects the telehealth market will skyrocket to over $2 trillion by 2034, signaling a seismic shift in how we receive medical care.

With billions in government and private backing, USA Rare Earth hires legal, policy, and finance heavyweights to challenge China's grip on critical minerals.